Goh Boon Cher

基本信息

浏览量：289

职业迁徙

个人简介

Research Interest
Lung Cancer
Head & Neck Cancer
Phase I Clinical Trials

研究兴趣

论文共 384 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

ROS Modulation in the Current Landscape of Anti-Cancer Therapies

Jiaqi Li, Justin Yi Shen Lim,Jie Qing Eu, Andrew Kieran Ming Hui Chan,Boon Cher Goh,Lingzhi Wang,Andrea Li-Ann Wong

Antioxidants & redox signaling (2024)

引用0浏览0WOS引用

Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy

Xue-Bin Ran,Ling-Wen Ding,Qiao-Yang Sun,Henry Yang,Jonathan W Said,Lao Zhentang,Vikas Madan,Pushkar Dakle,Jin-Fen Xiao,Xinyi Loh,Ying Li,Liang Xu,

Cancer Res（2023）

引用2浏览0WOS引用

Supplementary Figure 5 from PPARγ Ligand–induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers

Luxi Chen,Yi Yuan, Shreya Kar, Madhu M. Kanchi,Suruchi Arora, Ji E. Kim, Pei F. Koh,Einas Yousef,Ramar P. Samy,Muthu K. Shanmugam,Tuan Z. Tan, Sung W. Shin,

crossref（2023）

引用0浏览0引用

1320MO Early evidence of efficacy in patients (pts) with non-small cell lung cancer (NSCLC) with HER2 exon20 insertion (ex20ins) mutations treated in a phase I study with BAY 2927088

H.H.F. Loong, G. Daniele,T-Y. Yang, T.A. Leal, K. Goto, Y. Shinno, K. Nishino, T. Sakamoto, E. Felip, J.C. Ruffinelli, N. Gallot, Z. Wang,

Annals of Oncology (2023): S761-S762

引用0浏览0引用

Supplementary Figure from Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer

Joline S.J. Lim,Andrea L.A. Wong,Samuel G.W. Ow,Natalie Y.L. Ngoi,Gloria H.J. Chan,Yvonne L.E. Ang,Wan Qin Chong,Siew Eng Lim,Yi Wan Lim,Matilda Lee,Joan R.E. Choo,Hon Lyn Tan,

crossref（2023）

引用4浏览0引用

Multinational Analysis of Estimated Health Care Costs Related to Extended-Interval Fixed Dosing of Checkpoint Inhibitors

Daniel A Goldstein,Gary M Ginsberg, Dorit Hofnung-Gabbay,Richard De Abreu Lourenco,Herbert H Loong,Boon Cher Goh,Kelvin K W Chan,Massimo Di Maio,Francesco Perrone,Peter S Hall,Alona Zer,Eli Rosenbaum

JAMA Netw Open（2023）

引用1浏览0WOS引用

A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study)

Yvonne L. E. Ang,Xiaotian Zhao,Thanyanan Reungwetwattana,Byoung-Chul Cho,Bin-Chi Liao,Rebecca Yeung,Herbert H. Loong,Dong-Wan Kim,James Chih-Hsin Yang,Sun Min Lim,Myung-Ju Ahn,Se-Hoon Lee,

Cancersno. 20 (2023)

引用0浏览0WOS引用

Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials

Jerold Loh,Jiaxuan Wu,Jenny Chieng,Aurora Chan,Wei-Peng Yong,Raghav Sundar,Soo-Chin Lee,Andrea Wong,Joline S. J. Lim,David S. P. Tan,Ross Soo,Boon-Cher Goh,

BRITISH JOURNAL OF CANCERno. 8 (2023): 1514-1520

引用0浏览0引用

FAM3C in circulating tumor-derived extracellular vesicles promotes non-small cell lung cancer growth in secondary sites

Win Lwin Thuya,Li Ren Kong,Nicholas L Syn,Ling-Wen Ding,Esther Sok Hwee Cheow, Regina Tong Xin Wong,Tingting Wang,Robby Miguel Wen-Jing Goh,Hongyan Song,Migara K Jayasinghe,Minh Tn Le,Jian Cheng Hu,

Theranostics（2023）

引用3浏览0WOS引用

A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies

Cheng Ean Chee,Melissa Ooi,Soo‐Chin Lee,Raghav Sundar,Valerie Heong,Wei-Peng Yong,Chin Hin Ng,Andrew Barnabas Wong,Joline S.J. Lim,David Sp Tan,Ross A. Soo, Joshua T C Tan,

Targeted oncologyno. 3 (2023): 391-402

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

教授

论文共 384 篇作者统计合作学者相似作者